| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44000478 | HTLV-1 | ENSG00000175868.14 | protein_coding | CALCB | No | No | 797 | P10092 |
| TVIS44026562 | HTLV-1 | ENSG00000175868.14 | protein_coding | CALCB | No | No | 797 | P10092 |
| TVIS44026563 | HTLV-1 | ENSG00000175868.14 | protein_coding | CALCB | No | No | 797 | P10092 |
| TVIS44026564 | HTLV-1 | ENSG00000175868.14 | protein_coding | CALCB | No | No | 797 | P10092 |
| TVIS44032160 | HTLV-1 | ENSG00000175868.14 | protein_coding | CALCB | No | No | 797 | P10092 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CALCB |
|---|---|
| DrugBank ID | DB14042 |
| Drug Name | Galcanezumab |
| Target ID | BE0002370 |
| UniProt ID | P10092 |
| Regulation Type | antibody |
| PubMed IDs | 29089894 |
| Citations | Monteith D, Collins EC, Vandermeulen C, Van Hecken A, Raddad E, Scherer JC, Grayzel D, Schuetz TJ, de Hoon J: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers. Front Pharmacol. 2017 Oct 17;8:740. doi: 10.3389/fphar.2017.00740. eCollection 2017. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
